table of content
1 Study Coverage
1.1 PET Radiopharmaceuticals Product Introduction
1.2 Market by Type
1.2.1 Global PET Radiopharmaceuticals Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 F-18
1.2.3 Ru-82
1.2.4 Others
1.3 Market by Application
1.3.1 Global PET Radiopharmaceuticals Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Neurology
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global PET Radiopharmaceuticals Sales Estimates and Forecasts 2017-2028
2.2 Global PET Radiopharmaceuticals Revenue Estimates and Forecasts 2017-2028
2.3 Global PET Radiopharmaceuticals Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global PET Radiopharmaceuticals Sales by Region
2.4.1 Global PET Radiopharmaceuticals Sales by Region (2017-2022)
2.4.2 Global Sales PET Radiopharmaceuticals by Region (2023-2028)
2.5 Global PET Radiopharmaceuticals Revenue by Region
2.5.1 Global PET Radiopharmaceuticals Revenue by Region (2017-2022)
2.5.2 Global PET Radiopharmaceuticals Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global PET Radiopharmaceuticals Sales by Manufacturers
3.1.1 Global Top PET Radiopharmaceuticals Manufacturers by Sales (2017-2022)
3.1.2 Global PET Radiopharmaceuticals Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of PET Radiopharmaceuticals in 2021
3.2 Global PET Radiopharmaceuticals Revenue by Manufacturers
3.2.1 Global PET Radiopharmaceuticals Revenue by Manufacturers (2017-2022)
3.2.2 Global PET Radiopharmaceuticals Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by PET Radiopharmaceuticals Revenue in 2021
3.3 Global PET Radiopharmaceuticals Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global PET Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global PET Radiopharmaceuticals Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global PET Radiopharmaceuticals Sales by Type
4.1.1 Global PET Radiopharmaceuticals Historical Sales by Type (2017-2022)
4.1.2 Global PET Radiopharmaceuticals Forecasted Sales by Type (2023-2028)
4.1.3 Global PET Radiopharmaceuticals Sales Market Share by Type (2017-2028)
4.2 Global PET Radiopharmaceuticals Revenue by Type
4.2.1 Global PET Radiopharmaceuticals Historical Revenue by Type (2017-2022)
4.2.2 Global PET Radiopharmaceuticals Forecasted Revenue by Type (2023-2028)
4.2.3 Global PET Radiopharmaceuticals Revenue Market Share by Type (2017-2028)
4.3 Global PET Radiopharmaceuticals Price by Type
4.3.1 Global PET Radiopharmaceuticals Price by Type (2017-2022)
4.3.2 Global PET Radiopharmaceuticals Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global PET Radiopharmaceuticals Sales by Application
5.1.1 Global PET Radiopharmaceuticals Historical Sales by Application (2017-2022)
5.1.2 Global PET Radiopharmaceuticals Forecasted Sales by Application (2023-2028)
5.1.3 Global PET Radiopharmaceuticals Sales Market Share by Application (2017-2028)
5.2 Global PET Radiopharmaceuticals Revenue by Application
5.2.1 Global PET Radiopharmaceuticals Historical Revenue by Application (2017-2022)
5.2.2 Global PET Radiopharmaceuticals Forecasted Revenue by Application (2023-2028)
5.2.3 Global PET Radiopharmaceuticals Revenue Market Share by Application (2017-2028)
5.3 Global PET Radiopharmaceuticals Price by Application
5.3.1 Global PET Radiopharmaceuticals Price by Application (2017-2022)
5.3.2 Global PET Radiopharmaceuticals Price Forecast by Application (2023-2028)
6 North America
6.1 North America PET Radiopharmaceuticals Market Size by Type
6.1.1 North America PET Radiopharmaceuticals Sales by Type (2017-2028)
6.1.2 North America PET Radiopharmaceuticals Revenue by Type (2017-2028)
6.2 North America PET Radiopharmaceuticals Market Size by Application
6.2.1 North America PET Radiopharmaceuticals Sales by Application (2017-2028)
6.2.2 North America PET Radiopharmaceuticals Revenue by Application (2017-2028)
6.3 North America PET Radiopharmaceuticals Market Size by Country
6.3.1 North America PET Radiopharmaceuticals Sales by Country (2017-2028)
6.3.2 North America PET Radiopharmaceuticals Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe PET Radiopharmaceuticals Market Size by Type
7.1.1 Europe PET Radiopharmaceuticals Sales by Type (2017-2028)
7.1.2 Europe PET Radiopharmaceuticals Revenue by Type (2017-2028)
7.2 Europe PET Radiopharmaceuticals Market Size by Application
7.2.1 Europe PET Radiopharmaceuticals Sales by Application (2017-2028)
7.2.2 Europe PET Radiopharmaceuticals Revenue by Application (2017-2028)
7.3 Europe PET Radiopharmaceuticals Market Size by Country
7.3.1 Europe PET Radiopharmaceuticals Sales by Country (2017-2028)
7.3.2 Europe PET Radiopharmaceuticals Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific PET Radiopharmaceuticals Market Size by Type
8.1.1 Asia Pacific PET Radiopharmaceuticals Sales by Type (2017-2028)
8.1.2 Asia Pacific PET Radiopharmaceuticals Revenue by Type (2017-2028)
8.2 Asia Pacific PET Radiopharmaceuticals Market Size by Application
8.2.1 Asia Pacific PET Radiopharmaceuticals Sales by Application (2017-2028)
8.2.2 Asia Pacific PET Radiopharmaceuticals Revenue by Application (2017-2028)
8.3 Asia Pacific PET Radiopharmaceuticals Market Size by Region
8.3.1 Asia Pacific PET Radiopharmaceuticals Sales by Region (2017-2028)
8.3.2 Asia Pacific PET Radiopharmaceuticals Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America PET Radiopharmaceuticals Market Size by Type
9.1.1 Latin America PET Radiopharmaceuticals Sales by Type (2017-2028)
9.1.2 Latin America PET Radiopharmaceuticals Revenue by Type (2017-2028)
9.2 Latin America PET Radiopharmaceuticals Market Size by Application
9.2.1 Latin America PET Radiopharmaceuticals Sales by Application (2017-2028)
9.2.2 Latin America PET Radiopharmaceuticals Revenue by Application (2017-2028)
9.3 Latin America PET Radiopharmaceuticals Market Size by Country
9.3.1 Latin America PET Radiopharmaceuticals Sales by Country (2017-2028)
9.3.2 Latin America PET Radiopharmaceuticals Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa PET Radiopharmaceuticals Market Size by Type
10.1.1 Middle East and Africa PET Radiopharmaceuticals Sales by Type (2017-2028)
10.1.2 Middle East and Africa PET Radiopharmaceuticals Revenue by Type (2017-2028)
10.2 Middle East and Africa PET Radiopharmaceuticals Market Size by Application
10.2.1 Middle East and Africa PET Radiopharmaceuticals Sales by Application (2017-2028)
10.2.2 Middle East and Africa PET Radiopharmaceuticals Revenue by Application (2017-2028)
10.3 Middle East and Africa PET Radiopharmaceuticals Market Size by Country
10.3.1 Middle East and Africa PET Radiopharmaceuticals Sales by Country (2017-2028)
10.3.2 Middle East and Africa PET Radiopharmaceuticals Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Cardinal Health Inc. (U.S.)
11.1.1 Cardinal Health Inc. (U.S.) Corporation Information
11.1.2 Cardinal Health Inc. (U.S.) Overview
11.1.3 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Cardinal Health Inc. (U.S.) Recent Developments
11.2 Mallinckrodt plc (Ireland)
11.2.1 Mallinckrodt plc (Ireland) Corporation Information
11.2.2 Mallinckrodt plc (Ireland) Overview
11.2.3 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Mallinckrodt plc (Ireland) Recent Developments
11.3 GE Healthcare (U.K.)
11.3.1 GE Healthcare (U.K.) Corporation Information
11.3.2 GE Healthcare (U.K.) Overview
11.3.3 GE Healthcare (U.K.) PET Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 GE Healthcare (U.K.) PET Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GE Healthcare (U.K.) Recent Developments
11.4 Lantheus Medical Imaging, Inc. (U.S.)
11.4.1 Lantheus Medical Imaging, Inc. (U.S.) Corporation Information
11.4.2 Lantheus Medical Imaging, Inc. (U.S.) Overview
11.4.3 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Lantheus Medical Imaging, Inc. (U.S.) Recent Developments
11.5 Bayer AG (Germany)
11.5.1 Bayer AG (Germany) Corporation Information
11.5.2 Bayer AG (Germany) Overview
11.5.3 Bayer AG (Germany) PET Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Bayer AG (Germany) PET Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Bayer AG (Germany) Recent Developments
11.6 Bracco Imaging S.p.A (Italy)
11.6.1 Bracco Imaging S.p.A (Italy) Corporation Information
11.6.2 Bracco Imaging S.p.A (Italy) Overview
11.6.3 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bracco Imaging S.p.A (Italy) Recent Developments
11.7 Eczacibasi-Monrol Nuclear Products (Turkey)
11.7.1 Eczacibasi-Monrol Nuclear Products (Turkey) Corporation Information
11.7.2 Eczacibasi-Monrol Nuclear Products (Turkey) Overview
11.7.3 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Eczacibasi-Monrol Nuclear Products (Turkey) Recent Developments
11.8 Nordion, Inc. (Canada)
11.8.1 Nordion, Inc. (Canada) Corporation Information
11.8.2 Nordion, Inc. (Canada) Overview
11.8.3 Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Nordion, Inc. (Canada) PET Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Nordion, Inc. (Canada) Recent Developments
11.9 Advanced Accelerator Applications S.A. (France)
11.9.1 Advanced Accelerator Applications S.A. (France) Corporation Information
11.9.2 Advanced Accelerator Applications S.A. (France) Overview
11.9.3 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Advanced Accelerator Applications S.A. (France) Recent Developments
11.10 IBA Molecular Imaging (Belgium)
11.10.1 IBA Molecular Imaging (Belgium) Corporation Information
11.10.2 IBA Molecular Imaging (Belgium) Overview
11.10.3 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 IBA Molecular Imaging (Belgium) Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 PET Radiopharmaceuticals Industry Chain Analysis
12.2 PET Radiopharmaceuticals Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 PET Radiopharmaceuticals Production Mode & Process
12.4 PET Radiopharmaceuticals Sales and Marketing
12.4.1 PET Radiopharmaceuticals Sales Channels
12.4.2 PET Radiopharmaceuticals Distributors
12.5 PET Radiopharmaceuticals Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 PET Radiopharmaceuticals Industry Trends
13.2 PET Radiopharmaceuticals Market Drivers
13.3 PET Radiopharmaceuticals Market Challenges
13.4 PET Radiopharmaceuticals Market Restraints
14 Key Findings in The Global PET Radiopharmaceuticals Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
